Posts

Showing posts with the label Non-Cystic Fibrosis Bronchiectasis (NCFB)

Non-Cystic Fibrosis Bronchiectasis (NCFB) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 Non-cystic fibrosis bronchiectasis (NCFB) is a chronic, progressive lung disease that causes the airways to become permanently widened and abnormal. People with NCFB often have chronic coughs, produce mucus, and get repeated lung infections. The symptoms of NCFB can range from mild to severe. Some people have no symptoms, while others may experience massive lung bleeding or respiratory failure. The most common symptom of NCFB is a chronic cough. Many people with NCFB have a cough that produces mucus for over 30 years before they are diagnosed. Other common symptoms include shortness of breath, fatigue, chronic sinus infections, and ear, nose, and throat surgery. A smaller number of people with NCFB experience mild, intermittent bleeding from the lungs. However, in some cases, the bleeding can be severe and life-threatening. Many people with NCFB also require frequent hospital admissions for repeated pneumonia. Depression and anxiety are common in people with NCFB and can significa...

Non-Cystic Fibrosis Bronchiectasis (NCFB) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Image
 Non-cystic fibrosis bronchiectasis (NCFB) is an incurable pulmonary disorder characterized pathologically by permanent bronchial dilatation and severe bronchial inflammation and clinically by chronic productive cough and recurrent infectious exacerbations. It is further characterized by permanent dilatation of the airways leading to persistent cough, sputum production, dyspnoea, and recurrent exacerbations. Current clinical management is typically multifaceted and includes treatment of concurrent etiologic conditions, promotion of airway clearance, reduction in bronchial inflammation, and suppression or prevention of chronic bronchial infection. ·        In the USA, the incidence of cases of Non-cystic fibrosis bronchiectasis (NCFB) ranges from 33 to 79 cases for a 100,000 population. The prevalence cases range between 142 to 221 cases per 100,000 persons. ·        Women are more susceptible to this disease; the numbe...